Insights

Strategic backing Twenty Twenty Therapeutics is a joint venture between Verily Life Sciences and Santen, signaling strong industry backing and potential for partnerships with established players in AI, diagnostics, and eye care.

Mission driven Their focus on eliminating preventable blindness and improving access to affordable diagnostics and treatments highlights opportunities to align with medical device distributors and payer-focused collaborations seeking scalable eye-care solutions.

Early stage scale With a small team (2-10 employees) and revenue in the low to mid single digits, there is upside for service partnerships, contract development, and pilot programs to accelerate product commercialization.

Tech synergy Emphasis on AI, microelectronics, and digital technologies complements cloud-enabled diagnostics; potential sales angles include AI-powered imaging, remote monitoring, and integrated diagnostic platforms for ophthalmology.

Market readiness Recent leadership change and ongoing expansion plans suggest openness to strategic alliances, distribution arrangements, and co-development deals with mid-sized biopharma or medtech firms targeting eye-disease markets.

Twenty/Twenty Therapeutics Tech Stack

Twenty/Twenty Therapeutics uses 8 technology products and services including Amazon Web Services, Cloudflare CDN, jQuery Migrate, and more. Explore Twenty/Twenty Therapeutics's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Cloudflare CDN
    Content Delivery Network
  • jQuery Migrate
    Javascript Libraries
  • jQuery Mobile
    Mobile Frameworks
  • Kinsta
    Platform As A Service
  • Yoast SEO
    Search Engines
  • MonsterInsights
    Web Platform Extensions
  • Contact Form 7
    Web Platform Extensions

Twenty/Twenty Therapeutics's Email Address Formats

Twenty/Twenty Therapeutics uses at least 1 format(s):
Twenty/Twenty Therapeutics Email FormatsExamplePercentage
First.Last@twentytwenty.comJohn.Doe@twentytwenty.com
87%
FLast@twentytwenty.comJDoe@twentytwenty.com
5%
FirstLast@twentytwenty.comJohnDoe@twentytwenty.com
5%
LastFirst@twentytwenty.comDoeJohn@twentytwenty.com
3%

Frequently Asked Questions

What is Twenty/Twenty Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Twenty/Twenty Therapeutics's official website is twentytwenty.com and has social profiles on LinkedIn.

How much revenue does Twenty/Twenty Therapeutics generate?

Minus sign iconPlus sign icon
As of July 2026, Twenty/Twenty Therapeutics's annual revenue is estimated to be $1M - $10M.

What is Twenty/Twenty Therapeutics's NAICS code?

Minus sign iconPlus sign icon
Twenty/Twenty Therapeutics's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Twenty/Twenty Therapeutics have currently?

Minus sign iconPlus sign icon
As of July 2026, Twenty/Twenty Therapeutics has approximately 10 employees across 3 continents, including North AmericaAfricaEurope. Key team members include Clinical Affairs / Product Management: L. S.. Explore Twenty/Twenty Therapeutics's employee directory with LeadIQ.

What industry does Twenty/Twenty Therapeutics belong to?

Minus sign iconPlus sign icon
Twenty/Twenty Therapeutics operates in the Medical Equipment Manufacturing industry.

What technology does Twenty/Twenty Therapeutics use?

Minus sign iconPlus sign icon
Twenty/Twenty Therapeutics's tech stack includes Amazon Web ServicesCloudflare CDNjQuery MigratejQuery MobileKinstaYoast SEOMonsterInsightsContact Form 7.

What is Twenty/Twenty Therapeutics's email format?

Minus sign iconPlus sign icon
Twenty/Twenty Therapeutics's email format typically follows the pattern of First.Last@twentytwenty.com. Find more Twenty/Twenty Therapeutics email formats with LeadIQ.

When was Twenty/Twenty Therapeutics founded?

Minus sign iconPlus sign icon
Twenty/Twenty Therapeutics was founded in 2020.
Twenty/Twenty Therapeutics logo

Twenty/Twenty Therapeutics

Medical Equipment ManufacturingCalifornia, United States2-10 Employees

Twenty Twenty Therapeutics is a medical equipment company focused on advancing eye care through the integration of artificial intelligence, microelectronics, and scalable digital technologies. Its work centers on diagnostic and preventative solutions for eye diseases, with the aim of improving accessibility to intuitive and affordable diagnostics and treatments for patients and enabling doctors to deliver better outcomes. The business develops, markets, and commercializes innovations in diagnostics, sensing, and preventative, medical, and surgical treatments for ocular conditions.
Based in South San Francisco, California, the company emerged in 2020 as a joint venture between Verily Life Sciences and Santen, reflecting its position within the medical device and ophthalmology landscape. Twenty Twenty Therapeutics seeks to transform eye-care delivery by enabling patients to manage their vision between clinical visits, while providing clinicians with enhanced tools and workflows. The organization emphasizes an inclusive work environment and a diverse, collaborative culture as part of its operating approach.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2020
Employees
2-10

Section iconFunding & Financials

  • $1M - $10M

    Twenty/Twenty Therapeutics's revenue is estimated to be in the range of $1M - $10M

Section iconFunding & Financials

  • $1M - $10M

    Twenty/Twenty Therapeutics's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.